These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 349319

  • 1. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ, Kalowski S, Guest C.
    Med J Aust; 1978 Jan 28; 1(2):105-9. PubMed ID: 349319
    [Abstract] [Full Text] [Related]

  • 2. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M, Halttunen P, Saarinen P, Sarna S.
    Ann Clin Res; 1979 Dec 28; 11(6):249-52. PubMed ID: 398184
    [Abstract] [Full Text] [Related]

  • 3. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ, Wing LM, Mulligan J, Walkley J, Grygiel JJ, Graham JR, Chalmers JP.
    Med J Aust; 1980 Mar 08; 1(5):224-5. PubMed ID: 6990215
    [Abstract] [Full Text] [Related]

  • 4. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP, Korner PI, Tiller DJ, Bune AJ, Steiner JD, West MJ, Wing LM, Uther JF.
    Med J Aust; 1976 May 01; 1(18):650-3. PubMed ID: 781495
    [Abstract] [Full Text] [Related]

  • 5. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ, Louis WJ.
    Br J Clin Pharmacol; 1979 May 01; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [Abstract] [Full Text] [Related]

  • 6. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ, Armstrong BK, Nassim MA, Beilin LJ.
    Br J Clin Pharmacol; 1976 Aug 01; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A, Allonen H, Kleimola T.
    Int J Clin Pharmacol Biopharm; 1979 Feb 01; 17(2):71-5. PubMed ID: 422304
    [Abstract] [Full Text] [Related]

  • 8. Double-blind trial of labetalol.
    Kane J, Gregg I, Richards DA.
    Br J Clin Pharmacol; 1976 Aug 01; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [Abstract] [Full Text] [Related]

  • 9. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P, Aslam S, Sharma BK, Sharma PL, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb 01; 23(2):101-4. PubMed ID: 3886563
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL, Davies DM, Gales GM, Rao JG, Rawlins MD, Routledge PA.
    Br J Clin Pharmacol; 1979 Feb 01; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [Abstract] [Full Text] [Related]

  • 11. Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
    Hua AS, Myers JB, Kincaid-Smith P.
    Med J Aust; 1978 Jan 14; 1(1):45-8. PubMed ID: 368538
    [Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN, Barter C, Adam WR, Doyle AE.
    J Cardiovasc Pharmacol; 1982 Jan 14; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [Abstract] [Full Text] [Related]

  • 13. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF, Al-Khalidi A, Shaarbaf H, Tawfiq NH.
    Pharmatherapeutica; 1982 Jan 14; 3(2):133-9. PubMed ID: 7048338
    [Abstract] [Full Text] [Related]

  • 14. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN.
    Drugs; 1984 Jan 14; 28 Suppl 2():51-68. PubMed ID: 6151891
    [Abstract] [Full Text] [Related]

  • 15. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
    Dent R, Kellaway GS.
    N Z Med J; 1977 Sep 14; 86(595):213-5. PubMed ID: 305013
    [Abstract] [Full Text] [Related]

  • 16. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P, Pozet N, Sassard J, Vincent M.
    Nouv Presse Med; 1980 Mar 29; 9(15):1087-90. PubMed ID: 7008020
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment of hypertension with labetalol.
    Erichs M, Rothgardt NP, Andersson E.
    Postgrad Med J; 1980 Mar 29; 56 Suppl 2():53-6. PubMed ID: 7433343
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypertension with labetalol.
    Bolli P, Waal-Manning HJ, Simpson FO, Seeman HM.
    N Z Med J; 1977 Dec 28; 86(602):557-63. PubMed ID: 306082
    [Abstract] [Full Text] [Related]

  • 19. Experience with labetalol in hypertension.
    Bolli P, Waal-Manning J, Wood AJ, Simpson FO.
    Br J Clin Pharmacol; 1976 Aug 28; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [Abstract] [Full Text] [Related]

  • 20. Labetalol in resistant hypertension.
    Dargie HJ, Dollery CT, Daniel J.
    Br J Clin Pharmacol; 1976 Aug 28; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.